Braunstein Douglas L
SEC-identified person · CIK 1495110 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Talkspace, Inc. TALK | Director · See Remarks | filed 2020–2026 |
| USA Technologies INC USTT | Director | filed 2019–2024 |
| Hudson Executive Investment Corp. III HIII | Director | filed 2021–2022 |
| Hudson Executive Investment Corp. II HCII | Director | filed 2021–2022 |
| Cardtronics plc CATM | Director | filed 2018–2021 |
| Tivity Health, INC. TVTY | Officer | filed 2020–2020 |
| Corindus Vascular Robotics, Inc. CVRS | Director | filed 2018–2019 |
| Eagle Pharmaceuticals, INC. EGRX | Director | filed 2016–2019 |
| Jpmorgan Chase & CO jpmc*011 | Chief Financial Officer | filed 2010–2013 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.